Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model

MLA

Katarzyna Wanda Pancer, et al. “Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model.” Pharmaceutics, vol. 13, no. 4, Apr. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....efd02d822850896896781e5a100b8d7a&authtype=sso&custid=ns315887.

APA

Katarzyna Wanda Pancer, Mariangela Garofalo, Beate Rinner, Magdalena Wieczorek, Silke Schrom, Stefano Salmaso, Laura Bertinato, Lukasz Kuryk, & Monika Staniszewska. (2021). Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model. Pharmaceutics, 13(4).

Chicago

Katarzyna Wanda Pancer, Mariangela Garofalo, Beate Rinner, Magdalena Wieczorek, Silke Schrom, Stefano Salmaso, Laura Bertinato, Lukasz Kuryk, and Monika Staniszewska. 2021. “Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model.” Pharmaceutics 13 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....efd02d822850896896781e5a100b8d7a&authtype=sso&custid=ns315887.